Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
This study has been terminated.
(Inadequate patient accrual)
Sponsor:
Penn State University
Information provided by:
Penn State University
ClinicalTrials.gov Identifier:
NCT00934518
First received: July 7, 2009
Last updated: July 28, 2010
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | July 2016 (Final data collection date for primary outcome measure) |